Mitonco 2mg Injection is used in the treatment of certain kinds of cancer of pancreas, breast, lung, and stomach. It can be used alone or in combination with some medicines as part of combination chemotherapy. It works by interfering with the growth of cancer cells, which are eventually destroyed.

Mitonco 2mg Injection is given as an injection into vein under the supervision of a doctor and should not be self-administered. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include anemia (low number of red blood cells), decreased white blood cell count, increased bleeding tendency, loss of appetite, nausea, and vomiting. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.

Before taking this medicine, inform your doctor if you have medical conditions involving blood, kidney, and liver or if you are suffering from any breathing disorder. This medicine is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with kidney, liver and heart function during treatment with this medicine. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses of Mitonco Injection

Benefits of Mitonco Injection

In Breast cancer

Mitonco 2mg Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Mitonco 2mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

In Non-small cell lung cancer

Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Mitonco 2mg Injection helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

show less

Side effects of Mitonco Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Mitonco

Anemia (low number of red blood cells)
Decreased white blood cell count
Increased bleeding tendency
Loss of appetite
Nausea
Vomiting
Feeling of discomfort
Low blood platelets
Weight loss
Rash

How to use Mitonco Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Mitonco Injection works

Mitonco 2mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.

Safety advice

Alcohol

UNSAFE

Mitonco 2mg Injection may cause excessive drowsiness with alcohol.

Pregnancy

UNSAFE

Mitonco 2mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding

CAUTION

Mitonco 2mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving

UNSAFE

Mitonco 2mg Injection may cause side effects which could affect your ability to drive.
Mitonco 2mg Injection may cause nausea and vomiting and thereby reduce your reaction times to such an extent that the ability to drive a motor vehicle is impaired.

Kidney

CAUTION

Mitonco 2mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Mitonco 2mg Injection may be needed. Please consult your doctor.
Use of Mitonco 2mg Injection is not recommended in patients with end-stage kidney disease.

Liver

CAUTION

Mitonco 2mg Injection should be used with caution in patients with liver disease. Dose adjustment of Mitonco 2mg Injection may be needed. Please consult your doctor.
Use of Mitonco 2mg Injection may not be recommended in some patients with liver disease.

What if you forget to take Mitonco Injection?

If you miss a dose of Mitonco 2mg Injection, please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

No substitutes found for this medicine

Quick tips

Mitonco 2mg Injection is given as in injection or infusion under the supervision of a doctor only.
Do not skip any dose and complete the course as suggested by your doctor.
Use an effective method of birth control to avoid pregnancy while taking this medication.
Your doctor may get regular blood tests done to monitor your blood cell count (CBC), liver and kidney function.
It is advisable to drink plenty of water to stay hydrated while taking this medicine.
Inform your doctor if you experience a dry cough, shortness of breath and cracking sound while breathing.

Fact Box

Chemical Class

Antitumor Antibiotics

Habit Forming

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Cytotoxic Alkaloids

Interaction with drugs

Taking Mitonco with any of the following medicines can modify the effect of either of them and cause some undesirable side effects

Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted) (Injection Route) Severe

Please consult with your doctor regarding an appropriate time interval between Mitomycin and Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted). Mitomycin may reduce effica... More

Filgrastim (Injection Route) Severe

Avoid taking Filgrastim within the 24-hour period prior to and 24 hours after Mitomycin. Please consult with your doctor regardine appropriate time interval. Mitomycin may reduce e... More

Cholera Vaccine (Inactivated) (Oral Route) Severe

Please consult with your doctor regarding an appropriate time interval between Mitomycin and Cholera Vaccine (Inactivated). Mitomycin may reduce efficacy of Cholera Vaccine (Inacti... More

Vinorelbine (Injection Route) Severe

If concurrent use is essential, please consult with your doctor regarding appropriate time interval. Concurrent use may cause severe respiratory distress.

Purified Vi Polysaccharide Typhoid Vaccine (Injection Route) Severe

Please consult with your doctor regarding an appropriate time interval between Mitomycin and Purified Vi Polysaccharide Typhoid Vaccine. Mitomycin may reduce efficacy of Purified V... More

View all drug interactions

Patient concerns

I want to know the symptoms of cancer as I am a smoker

Dr. Vijay Sharnangat

Medical Oncology and Hematology

Symptoms for cancer depends upon which organ involved. For smokers , definitely chronic , they have possibility to develop lung cancer, head and neck cancers, oesophagus cancer, pancreatic cancer, stomach cancer and so more on. General symptoms would be like loss of appetite, weight loss, low grade fever in some cases, chronic cough for long time.

What is the purpose of Chemotherepy given at the time of radiotherapy in ca lung small cell carcinoma

Dr. Vijay Sharnangat

Medical Oncology and Hematology

This is given to enhance the therapeutic effect of radiation therapy which is curative for small cell lung cancer.

Related lab tests

Breast Cancer (CA 15.3/ ER/ PR)

Carcino Embryonic Antigen

Related ayurvedic ingredients

Olive oil

Barley

Oats

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1718-19.
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 952.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 931-32.
Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:
Mitomycin. BC Cancer Drug Manual; 1994 [revised 1 Apr. 2014]. [Accessed 26 Mar. 2019] (online) Available from: